358 related articles for article (PubMed ID: 27048159)
1. The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.
Huang FY; Wang H; Huang BT; Liu W; Peng Y; Zhang C; Xia TL; Wang PJ; Zuo ZL; Heng Y; Liu RS; Pu XB; Gui YY; Chen SJ; Zhu Y; Chen M
Cardiovasc Diabetol; 2016 Apr; 15():58. PubMed ID: 27048159
[TBL] [Abstract][Full Text] [Related]
2. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
[TBL] [Abstract][Full Text] [Related]
3. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
4. Association between direct measures of body composition and prognostic factors in chronic heart failure.
Oreopoulos A; Ezekowitz JA; McAlister FA; Kalantar-Zadeh K; Fonarow GC; Norris CM; Johnson JA; Padwal RS
Mayo Clin Proc; 2010 Jul; 85(7):609-17. PubMed ID: 20592169
[TBL] [Abstract][Full Text] [Related]
5. EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: an observational longitudinal study in patients undergoing coronary artery bypass graft surgery.
Holm J; Vidlund M; Vanky F; Friberg Ö; Håkanson E; Walther S; Svedjeholm R
Br J Anaesth; 2014 Jul; 113(1):75-82. PubMed ID: 24727704
[TBL] [Abstract][Full Text] [Related]
6. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
8. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
[TBL] [Abstract][Full Text] [Related]
10. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
11. The influence of age on the clinical implications of N-terminal pro-B-type natriuretic peptide in acute coronary syndrome.
Huang FY; Huang BT; Tsauo JY; Peng Y; Xia TL; Zhang C; Liu RS; Zuo ZL; Wang PJ; Heng Y; Liu W; Pu XB; Gui YY; Chen SJ; Liao YB; Zhu Y; Chen M
Intern Emerg Med; 2016 Dec; 11(8):1077-1086. PubMed ID: 27344578
[TBL] [Abstract][Full Text] [Related]
12. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
14. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
Das SR; Drazner MH; Dries DL; Vega GL; Stanek HG; Abdullah SM; Canham RM; Chung AK; Leonard D; Wians FH; de Lemos JA
Circulation; 2005 Oct; 112(14):2163-8. PubMed ID: 16203929
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea.
Maeder MT; Ammann P; Rickli H; Schoch OD; Korte W; Hürny C; Myers J; Münzer T
Sleep Breath; 2008 Mar; 12(1):7-16. PubMed ID: 17906885
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
17. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.
Dong M; Liao JK; Yan B; Li R; Zhang M; Yu CM
Int J Cardiol; 2013 Sep; 167(6):2813-9. PubMed ID: 22921817
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential outcome benefit from ACE inhibition after acute coronary syndrome: a biomarker approach using N-terminal proBNP.
Squire I; Quinn P; Narayan H; Khan S; Dhillon O; Ng K; Kelly D; Davies J; Ng L
Heart; 2010 Jun; 96(11):831-7. PubMed ID: 20478862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
